Literature DB >> 33715061

Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis.

Ioannis Bellos1,2, Vasilios Pergialiotis3, Despina N Perrea3.   

Abstract

BACKGROUND: Acute kidney injury represents a major adverse effect of vancomycin administration. The aim of the present study is to accumulate all biopsy-proven cases of vancomycin nephrotoxicity and assess the association of histopathological features with renal prognosis.
METHODS: Medline, Scopus, CENTRAL, Web of Science, and Clinicaltrials.gov were systematically searched from inception to 29 September 2020. All case reports/series providing individual data of patients with biopsy-proven vancomycin nephrotoxicity were held eligible. A time-to-event analysis was performed evaluating the effects of histological diagnosis on renal recovery.
RESULTS: Overall, 18 studies were included, comprising 21 patients. Acute tubulointerstitial nephritis was the predominant pattern in 9 patients and was associated with a significantly higher risk of permanent renal dysfunction (HR: 5.08, 95% CI: [1.05-24.50)] compared to acute tubular necrosis. Tubulitis and eosinophilic infiltration were the most common histopathological findings, while interstitial fibrosis was linked to significantly worse renal prognosis (HR: 5.55, 95% CI: 1.13-27.27). Immunofluorescence and electron microscopy features were non-specific. Obstruction by tubular casts composed of vancomycin aggregates and uromodulin has been identified as a new mechanism of nephrotoxicity.
CONCLUSIONS: Acute tubular necrosis and tubulointerstitial nephritis represent the main histological patterns of vancomycin-induced acute kidney injury. The presence of fibrosis in the context of interstitial inflammation may be linked to lower recovery rates and worse long-term renal outcomes. A novel cast nephropathy obstructive mechanism has been suggested, necessitating further confirmation. Large-scale studies should define the exact indications of kidney biopsy in cases with suspected vancomycin nephrotoxicity.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Acute kidney injury; Kidney biopsy; Nephrotoxicity; Vancomycin

Mesh:

Substances:

Year:  2021        PMID: 33715061     DOI: 10.1007/s11255-021-02831-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  46 in total

Review 1.  Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.

Authors:  Sepideh Elyasi; Hossein Khalili; Simin Dashti-Khavidaki; Amirhooshang Mohammadpour
Journal:  Eur J Clin Pharmacol       Date:  2012-03-13       Impact factor: 2.953

Review 2.  Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond.

Authors:  Natasha E Holmes; Steven Y C Tong; Joshua S Davis; Sebastiaan J van Hal
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

Review 3.  Vancomycin nephrotoxicity: a review.

Authors:  Kari A Mergenhagen; Angela R Borton
Journal:  J Pharm Pract       Date:  2014-09-28

Review 4.  The dosing and monitoring of vancomycin: what is the best way forward?

Authors:  Philip G Drennan; Evan J Begg; Sharon J Gardiner; Carl M J Kirkpatrick; Steve T Chambers
Journal:  Int J Antimicrob Agents       Date:  2018-12-29       Impact factor: 5.283

Review 5.  Drug-induced acute kidney injury: diverse mechanisms of tubular injury.

Authors:  Mark A Perazella
Journal:  Curr Opin Crit Care       Date:  2019-12       Impact factor: 3.687

6.  Nephrotoxicity of vancomycin, alone and with an aminoglycoside.

Authors:  M J Rybak; L M Albrecht; S C Boike; P H Chandrasekar
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

7.  Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury.

Authors:  Selvinaz Dalaklioglu; Merih Tekcan; Nazli Ece Gungor; Ciler Celik-Ozenci; Nazif Hikmet Aksoy; Asli Baykal; Arda Tasatargil
Journal:  Toxicol Lett       Date:  2009-10-13       Impact factor: 4.372

Review 8.  Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis.

Authors:  I Bellos; V Karageorgiou; V Pergialiotis; D N Perrea
Journal:  Clin Microbiol Infect       Date:  2020-03-25       Impact factor: 8.067

9.  Relationship of vancomycin trough levels with acute kidney injury risk: an exposure-toxicity meta-analysis.

Authors:  Ioannis Bellos; Georgios Daskalakis; Vasilios Pergialiotis
Journal:  J Antimicrob Chemother       Date:  2020-10-01       Impact factor: 5.790

Review 10.  The Nephrotoxicity of Vancomycin.

Authors:  E J Filippone; W K Kraft; J L Farber
Journal:  Clin Pharmacol Ther       Date:  2017-06-05       Impact factor: 6.875

View more
  4 in total

1.  Severe AKI in a Patient on Multiple Antimicrobial Agents for Leg Infection.

Authors:  Anam Rehan; Gilbert W Moeckel; Mark A Perazella
Journal:  Kidney360       Date:  2022-02-24

2.  Case Report: Vancomycin-Associated Tubulointerstitial Nephritis in Clinical Practice-Case Report and Review of Literature.

Authors:  Lakshmi Kannan; Rishi Raj
Journal:  Front Med (Lausanne)       Date:  2022-05-31

3.  Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: COMMENTARY.

Authors:  Mark A Perazella
Journal:  Kidney360       Date:  2022-01-26

Review 4.  Vancomycin-Associated Acute Kidney Injury: A Narrative Review from Pathophysiology to Clinical Application.

Authors:  Wei-Chih Kan; Yi-Chih Chen; Vin-Cent Wu; Chih-Chung Shiao
Journal:  Int J Mol Sci       Date:  2022-02-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.